AMAG News and Press, AMAG Pharmaceuticals Inc.

WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHP...

Merger activity increased last week with four new deals announced. The acquisition of HD Supply Holdings by The Home Depot. The acquisition of Foundation Building Materials by American Securities. For further details see: Merger Arbitrage Mondays - Home Depot B...

Virtusa receives shareholder approval. Virtusa still has outstanding regulatory hurdles to clear. Merger arbitrage cash spreads generate positive returns for the 8th straight week. For further details see: Merger Arbitrage Analysis And Spread Performance - November 22, 2...

MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600 MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&...

NEW YORK, NY / ACCESSWIRE / October 21, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Cov...

WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s (FDA) proposal to withdraw its approval of Makena ® , the only F...

Merger activity decreased last week with four new deals announced. The acquisition of MyoKardia by Bristol Myers Squibb Company. The acquisition of Eaton Vance by Morgan Stanley. For further details see: Merger Arbitrage Mondays - Bristol Myers Squibb...

Merger activity increased significantly last week with ten new deals announced. The merger of WPX Energy (WPX) and Devon Energy Corporation (DVN). Morgan Stanley (MS) completes the acquisition of E*TRADE Financial Corporation (ETFC). For further details see: Me...

Kodiak Sciences reports initiation of Phase 3 trial of KSI-301. Incyte announces peptide-centric strategic collaboration with Nimble. AMAG receives a setback as the FDA rejects Makena. For further details see: Kodiak Initiates Phase 3 Trial, And Other News: The Good, Bad...

AMAG Pharmaceuticals (AMAG) has received FDA notification that the Agency is proposing to withdraw approval of Makena (hydroxyprogesterone caproate injection), a treatment approved to reduce preterm birth in pregnant women who have had a prior spontaneous preterm birth.The FDA also notif...